LUCARELLI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 10.813
AS - Asia 4.186
EU - Europa 3.419
SA - Sud America 1.184
AF - Africa 187
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 19.799
Nazione #
US - Stati Uniti d'America 10.625
SG - Singapore 1.656
IT - Italia 1.178
BR - Brasile 962
CN - Cina 900
HK - Hong Kong 538
SE - Svezia 452
RU - Federazione Russa 432
VN - Vietnam 361
DE - Germania 327
FR - Francia 239
FI - Finlandia 206
GB - Regno Unito 188
IN - India 141
UA - Ucraina 140
BD - Bangladesh 132
CA - Canada 103
AR - Argentina 83
IQ - Iraq 67
BE - Belgio 62
ID - Indonesia 56
ZA - Sudafrica 48
MX - Messico 46
TR - Turchia 44
CO - Colombia 43
JP - Giappone 40
SA - Arabia Saudita 40
CI - Costa d'Avorio 37
NL - Olanda 34
PK - Pakistan 33
ES - Italia 28
VE - Venezuela 28
EC - Ecuador 26
IE - Irlanda 23
PL - Polonia 23
PH - Filippine 20
MA - Marocco 19
TN - Tunisia 18
UZ - Uzbekistan 18
KE - Kenya 14
EG - Egitto 13
IR - Iran 13
JO - Giordania 13
AE - Emirati Arabi Uniti 12
AT - Austria 12
LT - Lituania 12
MY - Malesia 12
NP - Nepal 11
AZ - Azerbaigian 10
CL - Cile 9
KR - Corea 9
OM - Oman 9
PY - Paraguay 9
CH - Svizzera 8
UY - Uruguay 8
BO - Bolivia 7
HN - Honduras 7
JM - Giamaica 7
PE - Perù 7
TH - Thailandia 7
AL - Albania 6
DZ - Algeria 6
KZ - Kazakistan 6
LB - Libano 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
AU - Australia 5
CZ - Repubblica Ceca 5
ET - Etiopia 5
IL - Israele 5
SN - Senegal 5
SY - Repubblica araba siriana 5
AO - Angola 4
BG - Bulgaria 4
BY - Bielorussia 4
CR - Costa Rica 4
GE - Georgia 4
RO - Romania 4
RS - Serbia 4
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
NI - Nicaragua 3
AM - Armenia 2
BB - Barbados 2
EU - Europa 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
LC - Santa Lucia 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
RE - Reunion 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 19.767
Città #
Fairfield 1.261
Ashburn 1.183
Woodbridge 902
Singapore 896
Chandler 788
Houston 588
Hong Kong 537
Seattle 522
Cambridge 476
San Jose 470
Wilmington 387
Milan 378
Nyköping 357
Ann Arbor 326
Beijing 303
Jacksonville 277
New York 230
Bari 164
Los Angeles 161
Lawrence 155
Roxbury 155
Lauterbourg 147
Rome 143
Dallas 124
Munich 118
Ho Chi Minh City 117
Nanjing 113
São Paulo 104
Des Moines 99
Council Bluffs 86
Helsinki 81
Santa Clara 78
Princeton 77
Hanoi 68
Boardman 64
Buffalo 64
Brussels 60
Columbus 59
London 59
Brooklyn 55
Inglewood 52
San Diego 51
Dearborn 44
Figino 42
Abidjan 37
Frankfurt am Main 37
Chicago 36
Jakarta 36
Shenyang 36
The Dalles 36
Dong Ket 35
Hebei 34
Redwood City 32
Montreal 31
Turin 31
Tokyo 30
Turku 29
Paris 28
Rio de Janeiro 28
Nanchang 27
Orem 26
Baghdad 25
Dublin 25
Pune 25
Brasília 24
Jiaxing 24
Tianjin 24
Toronto 24
Atlanta 23
Boston 22
Falkenstein 22
Belo Horizonte 21
Campinas 21
Moscow 21
Changsha 19
Phoenix 19
Stockholm 19
Augusta 17
Chennai 17
Guangzhou 17
Mexico City 17
San Francisco 17
Warsaw 17
Curitiba 16
Johannesburg 16
Medellín 16
Caracas 15
Denver 15
Jeddah 15
Tashkent 15
Amsterdam 14
Bitonto 14
Bogotá 13
Bologna 13
Dhaka 13
Falls Church 13
Shanghai 13
Buenos Aires 12
Da Nang 12
Manaus 12
Totale 13.667
Nome #
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 266
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 229
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 228
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 216
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 214
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 211
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function 207
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury 205
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 203
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 200
Isolation and characterization of cancer stem cells in renal cell carcinoma. 196
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 196
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation. 187
Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature 183
Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study 181
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 174
Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report 173
Androgen deprivation therapy affects BCL-2 expression in human prostate cancer 172
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 171
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 169
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 169
Allograft nephrectomy: what is the best surgical technique? 169
Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. 168
Capillary hemangioma of the scrotum mimicking an epididymal tumor: case report. 165
Complement activation during ischemia/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary Lumen Reduction Through pERK Signaling 161
Penile prosthesis implant: when, what and how 159
Experience of percutaneous access under ultrasound guidance in renal transplant patients with allograft lithiasis 159
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 158
A challenging surgical approach to locally advanced primary urethral carcinoma: A case report and literature review 157
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 150
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 149
DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via Complement-mediated cellular senescence 148
Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years 146
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 145
Androgen deprivation therapy regulation of beta 1C integrin expression in prostate cancer 143
Emerging urinary markers of renal injury in obstructive nephropathy. 140
"Deviceless" hand-assisted laparoscopic donor nephrectomy 138
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma 137
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 136
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 135
Complement-Mediated Acute Induction of Endothelial-to-Mesenchymal Transition in a Swine Model of Renal Ischemia/Reperfusion (I/R) Injury 135
Penile prosthesis: what should we do about complications? 133
A CLUSTER OF PROTEINS SECRETED BY HUMAN RENAL STEM/PROGENITOR CELLS (ARPCS) PROVIDE A NOVEL STRATEGY TO REVERT ENDOTHELIAL DYSFUNCTION AND RENAL INJURY IN SEPSIS-INDUCED ACUTE KIDNEY INJURY (AKI) 132
Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction 131
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 129
Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury 129
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage 128
DIABETES MELLITUS IN RENAL CELL CARCINOMA: ROLE OF OGG1 AND TUBERIN 127
DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA . 127
The emerging role of obesity, diet and lipid metabolism in prostate cancer 126
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 126
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 125
Incidental prostatic cancer: repeat TURP or biopsy? 125
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review 125
Editorial comment from Dr Lucarelli and Dr Ditonno to Impact of graft nephrectomy on outcomes of second kidney transplantation. 123
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 123
Patient and partner satisfaction after AMS inflatable penile prosthesis implant 122
Emerging biomarkers in renal damage. 121
Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma 121
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 120
null 119
Obesity in kidney transplantation affects renal function but not graft and patient survival 119
Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study 119
Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population. 118
B3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Insipidus 116
Management of severe complications following penile surgery for erectile dysfunction and Peyronie disease: Three case reports 116
Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway 115
Middle and long-term outcomes of dual kidney transplant: a multicenter experience 113
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer 111
36-kDa Annexin A3 Isoform Negatively Modulates Lipid Storage in Clear Cell Renal Cell Carcinoma Cells 111
Hem-O-Lok clip: A neglected cause of severe bladder neck contracture and consequent urinary incontinence after robot-assisted laparoscopic radical prostatectomy 110
null 109
Transperitoneal deviceless hand-assisted laparoscopic living donor nephrectomy: an alternative technique for kidney recovery 108
LAMININA 5 COME MARKER NELLA DIAGNOSI E NELLA PROGNOSI DEL CARCINOMA UROTELIALE DELLA VESCICA 108
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 107
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas 107
Aligned Nanofiber Topographies Enhance the Differentiation of Adult Renal Stem Cells into Glomerular Podocytes 107
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 106
Complement Mediated Endothelial Cell (EC) Activation in a Swine Model of Renal Ischemia/Reperfusion (I/R) Injury 106
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 106
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 105
ASSOCIATION OF N-ACETYLTRANSFERASE 2 POLYMORPHISM WITH RISK FACTORS IN UROTHELIAL CANCER. 105
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 104
Incidentally discovered yellowish lesions in a renal graft from a deceased donor 104
DIABETES MELLITUS IS A RISK FACTOR FOR PROGRESSION IN RENAL CELL CARCINOMA 103
Testicular granulosa cell tumor of adult type: a new case and a review of the literature 102
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation 101
Ischemia-Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets. 99
RENAL CELL CARCINOMA: DOES TRANSCRIPTIONAL DEREGULATION OF ADULT RENAL STEM/PROGENITOR CELLS LEAD TO ONCOGENESIS? 98
Impact of transplant nephrectomy on retransplantation: a single-center retrospective study. 97
MP067 MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM 97
Unusual solitary metastasis of the ciliary body in renal cell carcinoma 96
CARCINOMA DELLA PROSTATA 95
THE DIAGNOSTIC ROLE OF CA 15-3, CA 125 AND BETA2-MICROGLOBULIN IN RENAL CELL CARCINOMA 95
Surgery for renal cell carcinoma in two European urologic clinics: to compare or compete? 93
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 92
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer 92
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome 92
Extended Criteria Donor Kidney Transplantation: Comparative Outcome Analysis of Score 4 Graft Used as Single Transplant Versus Double Kidney Transplantation 90
CTR2 Identifies a Population of Cancer Cells with Stem-Like Features in Patients with Clear Cell Renal Cell Carcinoma. 90
Totale 13.722
Categoria #
all - tutte 86.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.109 71 95 18 35 42 103 42 64 71 118 164 286
2022/20231.890 288 228 129 171 187 259 25 239 279 16 45 24
2023/2024663 65 120 38 49 57 230 10 13 5 14 11 51
2024/20253.069 70 73 221 124 88 285 371 271 114 134 455 863
2025/20266.843 1.015 306 449 751 812 359 673 214 631 618 264 751
2026/2027130 130 0 0 0 0 0 0 0 0 0 0 0
Totale 20.383